Critical Elements of the Medical Device Administration
##plugins.themes.bootstrap3.article.main##
The vast growth of medical devices in recent years in both innovation and its overall marketplace has profoundly impacted the medical field. This paper analyzes the critical elements of the medical device administrative program and researches the impacts of the influences of the demonstrative imaging hardware industry. The outcomes have indicated that the medical device direction has not impacted or influenced rivalry or development inside the various classes in this industry. This paper contains recommendations comprising of selected strategies for control that separate among levels of potential hazards to purchasers in which the objective of achieving buyer assurance can be accomplished with fewer undesirable consequences for the controlled business.
Downloads
References
-
Leahey, M.B., “FDA is gold standard of review,” BMJ: British Medical Journal, 2010. 341(7785): pp. 1235-1235.
Google Scholar
1
-
Grennan, M., “”Price Discrimination and Bargaining: Empirical Evidence from Medical Devices,” The American Economic Review, 2013. 103(1): p. 145-177.
Google Scholar
2
-
Makow, L.S., “Medical Device Review at the Food and Drug Administration: Lessons from Magnetic Resonance Spectroscopy and Biliary Lithotripsy,” Stanford Law Review, 1994. 46(3): p. 709-746.
Google Scholar
3
-
Sloan, T., “First, Do No Harm? A Framework for Evaluating New versus Reprocessed Medical Devices,” The Journal of the Operational Research Society, 2010. 61(2): p. 191-201.
Google Scholar
4
-
Polisena, J., et al., “Reprocessing and Reuse of Single;Use Medical Devices: A National Survey of Canadian Acute; Care Hospitals,” Infection Control and Hospital Epidemiology, 2008. 29(5): p. 437-439.
Google Scholar
5
-
Bright, R.A., “The Conference on the Epidemiology of Medical Devices in Women,” Epidemiology, 2002. 13(3): p. S1-S9.
Google Scholar
6
-
Chester, A.R., T.E. Hoyer, and A.A. Thomas, “Encouraging Medical Device Innovation: Reimbursement Problems and New Policies,” Public Health Reports (1974-), 1996. 111(5): p. 468-470.
Google Scholar
7
-
Charatan, F., “US Confirms Federal Authority for Safety of Medical Devices,” BMJ: British Medical Journal, 2008. 336(7642): p. 470-470.
Google Scholar
8
-
Ludgate, S., “MRHA works hardto ensure that medical devices work and are safe,” BMJ: British Medical Journal, 2012. 344(7848): p. 30-30.
Google Scholar
9
-
McKay, N.L., “Industry Effects of Medical Device Regulation: The Case of Diagnostic Imaging Equipment,” Journal of Policy Analysis and Management, 1986. 6(1): p. 35-44.
Google Scholar
10
-
Nahnhauer, A. and W. Kaesbach, “Reimbursement of Medical Devices in Germany,” Health Economics in Prevention and Care, 2000. 1(2): p. 140-145.
Google Scholar
11
-
Spivak, J.M., “Regulation of Medical Devices,” The Annals of the American Academy of Political and Social Science, 1972. 400: p. 82-94.
Google Scholar
12
-
Torrence, M.E., “Data Sources: Use in the Epidemiologic Study of Medical Devices,” Epidemiology, 2002. 13(3): p. S10-S14.
Google Scholar
13
-
Gornall, J., “Medical Device or Consumer Product?” BMJ: British Medical Journal, 2012. 345(7876): p. 22-22.
Google Scholar
14
-
Ecchia, G. and L. Lambertini, “Minimum Quality Standards and Collusion,” The Journal of Industrial Economics, 1997. 45(1): p. 101-113.
Google Scholar
15
-
Ronnen, U., “Minimum Quality Standards, Fixed Costs, and Competition,” The RAND Journal of Economics, 1991. 22(4): p. 490-504.
Google Scholar
16
-
Boom, A., “Asymmetric International Minimum Quality Standards and Vertical Differentiation,” The Journal of Industrial Economics, 1995. 43(1): p. 101-119.
Google Scholar
17
-
Kluger, B.D., “Implications of Quality Standard Regulation for Multiproduct Monopoly Pricing,” Managerial and Decision Economics, 1989. 10(1): p. 61-67.
Google Scholar
18
-
Gross, P.A., et al., “Quality Standard for the Treatment of Bacteremia,” Clinical Infectious Diseases, 1994. 18(3): p. 428-430.
Google Scholar
19
-
Hansen, J., et al., “Economic Integration and Quality Standards in a Duopoly Model with Horizontal and Vertical Product Differentiation,” Journal of Economic Integration, 2006. 21(4): p. 837-860.
Google Scholar
20
-
McFarland, R.A., Human Biology, 1955. 27(3): p. 248-249.
Google Scholar
21
-
Ellis, W.S., Human Biology, 1967. 39(2): p. 205-207.
Google Scholar
22
-
Snyder, R.G., American Anthropologist, 1967. 69(5): p. 539-540.
Google Scholar
23
-
Clark, C.C., The Physical Measure of Man. Science, 1966. 154(3749): p. 638-638.
Google Scholar
24
-
Browne, R.C., British Journal of Industrial Medicine, 1954. 11(4): p. 308-308.
Google Scholar
25
-
Ryan, T.A., Industrial and Labor Relations Review, 1955. 8(3): p. 452-452.
Google Scholar
26
-
Nash, B., Product Development. Journal of Marketing, 1937. 1(3): p. 254-262.
Google Scholar
27
-
Hoopes, D.G., “Considering Risk in Product Development” Risk Management, 2001. 3(2): p. 7-15.
Google Scholar
28
-
Meyer, M.H. and D. Arthur, “Product Development for Services,” The Academy of Management Executive (1993-2005), 1999. 13(3): p. 64-76.
Google Scholar
29
-
McCarthy, E.J., “Organization for New-Product Development?,” The Journal of Business, 1959. 32(2): p. 128-132.
Google Scholar
30
-
Ittner, C.D. and D.F. Larcker, “Product Development Cycle Time and Organizational Performance,” Journal of Marketing Research, 1997. 34(1): p. 13-23.
Google Scholar
31
-
Sellstedt, B. and B. Naslund, “Product Development Plans,” Operational Research Quarterly (1970-1977), 1972. 23(4): p. 497-510.
Google Scholar
32
-
Sorenson, C. and M. Drummond, “Improving Medical Device Regulation: The United States and Europe in Perspective,” The Milbank Quarterly, 2014. 92(1): p. 114-150.
Google Scholar
33
-
Rettig, R.A., “The Federal Government and Medical Technology: Crossing Policy and Management Thresholds,” Policy Sciences, 1980. 11(3): p. 343-356.
Google Scholar
34
-
Cohen, D., “Reply to DePuy Criticisms,” BMJ: British Medical Journal, 2012. 344(7856): p. 31-32.
Google Scholar
35
-
Brennan, B.J., “The Need for Cooperation of Industry, Physicians and Government in Regulation of Medical Devices,” The Business Lawyer, 1970. 26(2): p. 365-376.
Google Scholar
36
-
Ein-Dor, P. and E. Segev, “Strategic Planning for Management Information Systems,” Management Science, 1978. 24(15): p. 1631-1641.
Google Scholar
37
-
Huff, C.B., et al., “Study of Ultraviolet Disinfection of Water and Factors in Treatment Efficiency,” Public Health Reports (1896-1970), 1965. 80(8): p. 695-705.
Google Scholar
38
-
Singh, M., “Surgical Instruments Industry at Jalandhar: A Case Study,” Economic and Political Weekly, 2002. 37(31): p. 3298-3304.
Google Scholar
39
-
Mackay, J., et al., “Voluntary Service Overseas,” The British Medical Journal, 1977. 1(6060): p. 572-573.
Google Scholar
40
-
Aizawa, M., “IFC's New Sustainability Performance Standards,” Natural Resources & Environment, 2006. 21(1): p. 62-70.
Google Scholar
41
-
Robinson, J.S., H.T. Davenport, and B.M. “Wright, Simple Oxygen-Failure Safety Device,” The British Medical Journal, 1974. 4(5941): p. 407-407.
Google Scholar
42
-
Oster, E., I. Shoulson, and E.R. Dorsey, “Optimal Expectations and Limited Medical Testing: Evidence from Huntington Disease,” The American Economic Review, 2013. 103(2): p. 804-830.
Google Scholar
43
-
Hamond-Gallardo, N., “More on Torture,” The American Journal of Nursing, 2005. 105(3): p. 15-15.
Google Scholar
44
-
Stack, K.M., “Interpreting Regulations,” Michigan Law Review, 2012. 111(3): p. 355-421.
Google Scholar
45
-
“FDA Action Plan Charts Priorities, Directions for the Future,” Public Health Reports (1974-), 1985. 100(6): p. 672-673.
Google Scholar
46
-
Buchanan, R.A., The Business History Review, 1993. 67(3): p. 492-493.
Google Scholar
47
-
Hansen, M., “Lawsuits Travel Up North: Land of Ten Thousand Lakes is flooded with thousands of out-of-state filings,” ABA Journal, 2007. 93(12): p. 16-17.
Google Scholar
48
-
Merrill, R.A., “The Architecture of Government Regulation of Medical Products,” Virginia Law Review, 1996. 82(8): p. 1753-1866.
Google Scholar
49
-
Muscarella, L.F., “Application of environmental sampling to flexible endoscope reprocessing: the importance of monitoring the rinse water,” Infection Control and Hospital Epidemiology, 2002. 23(5): p. 285-289.
Google Scholar
50
-
Gerald, M. and P. Burke, “The Challenge of Prion Decontamination,” Clinical Infectious Diseases, 2003. 36(9): p. 1152-1154.
Google Scholar
51
-
Murray, E.W., “From FDA Nurses: Probing the Safety of Central Venous Catheters,” The American Journal of Nursing, 1993. 93(5): p. 72-76.
Google Scholar
52
-
Chatterji, A.K., “Spawned with a Silver Spoon? Entrepreneurial Performance and Innovation in the Medical Device Industry,” Strategic Management Journal, 2009. 30(2): p. 185-206.
Google Scholar
53